tradingkey.logo

Rhythm Pharmaceuticals Announces Preliminary, Unaudited Fourth Quarter Results

ReutersJan 9, 2026 1:39 PM

- Rhythm Pharmaceuticals Inc RYTM.O:

  • RHYTHM PHARMACEUTICALS ANNOUNCES PRELIMINARY, UNAUDITED FOURTH QUARTER AND FULL YEAR 2025 NET PRODUCT REVENUES AND UPCOMING MILESTONES

  • RHYTHM PHARMACEUTICALS INC - MARCH 20, 2026 PDUFA GOAL DATE FOR SNDA FOR SETMELANOTIDE IN ACQUIRED HYPOTHALAMIC OBESITY

  • RHYTHM PHARMACEUTICALS INC - TOPLINE DATA FROM PHASE 3 EMANATE TRIAL EXPECTED Q1 2026

  • RHYTHM PHARMACEUTICALS INC - FY 2025 PRELIM PRODUCT REVENUES ABOUT $194 MILLION, UP 50% FROM FY2024

  • RHYTHM PHARMACEUTICALS INC - PRELIM Q4 2025 IMCIVREE REVENUES ABOUT $57 MILLION, UP 11% FROM Q3

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI